Phase 2 Borderline Resectable Pancreatic Adenocarcinoma trials recruiting now

All Borderline Resectable Pancreatic Adenocarcinoma trials, every phase

Phase 2 Borderline Resectable Pancreatic Adenocarcinoma trials

• HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation
  NCT07240766 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)
  NCT06384560 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma
  NCT05083247 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.